Breast cancer
Results
Phase 2
This trial looked at the combination of saracatinib with hormone therapy, for women with advanced breast cancer who had been through the menopause.
Recruitment start: 14 August 2012
Recruitment end: 7 May 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Cameron
AstraZeneca
Cancer Research UK
Common Services Agency
Experimental Cancer Medicine Centre (ECMC)
ISD Cancer Clinical Trials Team
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUKE/11/023.
Last reviewed: 8 July 2019
CRUK internal database number: 8283
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
